BIOMAT Database Logo BIOMAT Database Logo

Protection of mice with recombinant influenza virus neuraminidase. 2004

Edwin D Kilbourne, and Barbara A Pokorny, and Bert Johansson, and Ian Brett, and Youli Milev, and James T Matthews
Department of Microbiology and Immunology, New York Medical College, Valhalla, New York, USA. ekilbourne@snet.net

Contemporary influenza vaccines are standardized with respect to their content of hemagglutinin, the major virus antigen. Although the immunizing effect of viral neuraminidase--the less abundant of the 2 major surface glycoproteins--has been well documented in experimental animals, the importance of the purified recombinant protein has not yet been adequately assessed in animals or humans. We demonstrate that different lots of a baculovirus-derived recombinant N2 protein, in the absence of other influenza virus proteins, can induce neuraminidase-specific antibodies, reduce the replication of both homologous and heterovariant virus in mice, and suppress disease, as it is manifested by total body weight loss.

UI MeSH Term Description Entries
D007252 Influenza Vaccines Vaccines used to prevent infection by viruses in the family ORTHOMYXOVIRIDAE. It includes both killed and attenuated vaccines. The composition of the vaccines is changed each year in response to antigenic shifts and changes in prevalence of influenza virus strains. The flu vaccines may be mono- or multi-valent, which contains one or more ALPHAINFLUENZAVIRUS and BETAINFLUENZAVIRUS strains. Flu Vaccine,Influenzavirus Vaccine,Monovalent Influenza Vaccine,Universal Flu Vaccine,Universal Influenza Vaccine,Flu Vaccines,High-Dose Trivalent Influenza Vaccine,Influenza Vaccine,Influenza Virus Vaccine,Influenza Virus Vaccines,Influenzavirus Vaccines,Intranasal Live-Attenuated Influenza Vaccine,LAIV Vaccine,Monovalent Influenza Vaccines,Quadrivalent Influenza Vaccine,Trivalent Influenza Vaccine,Trivalent Live Attenuated Influenza Vaccine,Universal Flu Vaccines,Universal Influenza Vaccines,Flu Vaccine, Universal,High Dose Trivalent Influenza Vaccine,Influenza Vaccine, Monovalent,Influenza Vaccine, Quadrivalent,Influenza Vaccine, Trivalent,Influenza Vaccine, Universal,Intranasal Live Attenuated Influenza Vaccine,Vaccine, Flu,Vaccine, Influenza,Vaccine, Influenza Virus,Vaccine, Influenzavirus,Vaccine, LAIV,Vaccine, Monovalent Influenza,Vaccine, Quadrivalent Influenza,Vaccine, Trivalent Influenza,Virus Vaccine, Influenza
D008807 Mice, Inbred BALB C An inbred strain of mouse that is widely used in IMMUNOLOGY studies and cancer research. BALB C Mice, Inbred,BALB C Mouse, Inbred,Inbred BALB C Mice,Inbred BALB C Mouse,Mice, BALB C,Mouse, BALB C,Mouse, Inbred BALB C,BALB C Mice,BALB C Mouse
D009439 Neuraminidase An enzyme that catalyzes the hydrolysis of alpha-2,3, alpha-2,6-, and alpha-2,8-glycosidic linkages (at a decreasing rate, respectively) of terminal sialic residues in oligosaccharides, glycoproteins, glycolipids, colominic acid, and synthetic substrate. (From Enzyme Nomenclature, 1992) Sialidase,Exo-alpha-Sialidase,N-Acylneuraminate Glycohydrolases,Oligosaccharide Sialidase,Exo alpha Sialidase,Glycohydrolases, N-Acylneuraminate,N Acylneuraminate Glycohydrolases,Sialidase, Oligosaccharide
D009975 Orthomyxoviridae A family of RNA viruses causing INFLUENZA and other respiratory diseases. Orthomyxoviridae includes INFLUENZAVIRUS A; INFLUENZAVIRUS B; INFLUENZAVIRUS C; INFLUENZAVIRUS D; ISAVIRUS; and THOGOTOVIRUS. Influenza Viruses,Myxoviruses,Orthomyxoviruses,Influenza Virus,Myxovirus,Orthomyxovirus
D009976 Orthomyxoviridae Infections Virus diseases caused by the ORTHOMYXOVIRIDAE. Orthomyxovirus Infections,Infections, Orthomyxoviridae,Infections, Orthomyxovirus,Swine Influenza,Infection, Orthomyxoviridae,Infection, Orthomyxovirus,Influenza, Swine,Orthomyxoviridae Infection,Orthomyxovirus Infection
D011994 Recombinant Proteins Proteins prepared by recombinant DNA technology. Biosynthetic Protein,Biosynthetic Proteins,DNA Recombinant Proteins,Recombinant Protein,Proteins, Biosynthetic,Proteins, Recombinant DNA,DNA Proteins, Recombinant,Protein, Biosynthetic,Protein, Recombinant,Proteins, DNA Recombinant,Proteins, Recombinant,Recombinant DNA Proteins,Recombinant Proteins, DNA
D004195 Disease Models, Animal Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases. Animal Disease Model,Animal Disease Models,Disease Model, Animal
D005260 Female Females
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000914 Antibodies, Viral Immunoglobulins produced in response to VIRAL ANTIGENS. Viral Antibodies

Related Publications

Edwin D Kilbourne, and Barbara A Pokorny, and Bert Johansson, and Ian Brett, and Youli Milev, and James T Matthews
Protection of mice against a lethal influenza challenge by immunization with yeast-derived recombinant influenza neuraminidase.
July 1997, European journal of biochemistry,
Edwin D Kilbourne, and Barbara A Pokorny, and Bert Johansson, and Ian Brett, and Youli Milev, and James T Matthews
Infection of influenza virus neuraminidase-vaccinated mice with homologous influenza virus leads to strong protection against heterologous influenza viruses.
December 2014, The Journal of general virology,
Edwin D Kilbourne, and Barbara A Pokorny, and Bert Johansson, and Ian Brett, and Youli Milev, and James T Matthews
Vaccination with adjuvanted recombinant neuraminidase induces broad heterologous, but not heterosubtypic, cross-protection against influenza virus infection in mice.
March 2015, mBio,
Edwin D Kilbourne, and Barbara A Pokorny, and Bert Johansson, and Ian Brett, and Youli Milev, and James T Matthews
Protection against lethal influenza with neuraminidase.
May 1988, Virology,
Edwin D Kilbourne, and Barbara A Pokorny, and Bert Johansson, and Ian Brett, and Youli Milev, and James T Matthews
Immunization with recombinant Semliki Forest virus induces protection against influenza challenge in mice.
February 1999, Vaccine,
Edwin D Kilbourne, and Barbara A Pokorny, and Bert Johansson, and Ian Brett, and Youli Milev, and James T Matthews
Protection abilities of influenza B virus DNA vaccines expressing hemagglutinin, neuraminidase, or both in mice.
January 2008, Acta virologica,
Edwin D Kilbourne, and Barbara A Pokorny, and Bert Johansson, and Ian Brett, and Youli Milev, and James T Matthews
Antibody to Influenza Virus Neuraminidase: An Independent Correlate of Protection.
October 2015, The Journal of infectious diseases,
Edwin D Kilbourne, and Barbara A Pokorny, and Bert Johansson, and Ian Brett, and Youli Milev, and James T Matthews
Immunogenicity and Protection Against Influenza H7N3 in Mice by Modified Vaccinia Virus Ankara Vectors Expressing Influenza Virus Hemagglutinin or Neuraminidase.
March 2018, Scientific reports,
Edwin D Kilbourne, and Barbara A Pokorny, and Bert Johansson, and Ian Brett, and Youli Milev, and James T Matthews
Influenza virus neuraminidase.
May 1963, Marquette medical review,
Edwin D Kilbourne, and Barbara A Pokorny, and Bert Johansson, and Ian Brett, and Youli Milev, and James T Matthews
A CpG 1018 adjuvanted neuraminidase vaccine provides robust protection from influenza virus challenge in mice.
July 2022, NPJ vaccines,
Copied contents to your clipboard!